Targeting remission by 8 weeks: When should supplementation be considered in patients with major depression treated with a specific serotonin reuptake inhibitor?

Comprehensive Psychiatry

Volumn 52, Issue 1, 2011, Pages 9-16

  Cooper Kazaz, Rena ^a   Rigbi, Amihai ^a   Lerer, Bernard ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; PLACEBO; SERTRALINE;

ADULT; ARTICLE; FEMALE; HAMILTON ANXIETY SCALE; HAMILTON SCALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PREDICTION; RANDOMIZED CONTROLLED TRIAL; REMISSION; TREATMENT DURATION;

ADULT; CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LOGISTIC MODELS; MALE; ODDS RATIO; PSYCHIATRIC STATUS RATING SCALES; REMISSION INDUCTION; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; TIME FACTORS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 78651292672     PISSN: 0010440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.comppsych.2010.04.007     Document Type: Article

References (29)

1. Trivedi M.H., Rush A.J., Wisniewski S.R., Nierenberg A.A., Warden D., and Ritz L. Evaluation of outcome with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice Am J Psychiatry 163 2006 28 40
2. Nierenberg A.A., and DeCecco B.A. Definitions of antidepressant treatment response, remission, nonresponse, partial response and other relevant outcomes: a focus on treatment-resistant depression J Clin Psychiatry 62 16, suppl 2001 5 9
3. Rush A.J., Kraemer H.C., Sackeim H.A., Fava M., Trivedi M.H., and Frank E. Report by the ACNP task force on response and remission in major depressive disorder Neuropsychopharmacology 31 2006 1841 1853
4. Rush A.J., Trivedi M.H., Wisniewski S.R., Nierenberg A.A., Stewart J.W., and Warden D. STAR*D study team. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report Am J Psychiatry 163 2006 1905 1917
5. Blier P, Ward H. Towards optimal treatments for major depression. CNS Spectr 2002;7:148-50, 153-4.
6. Cooper-Kazaz R., and Lerer B. Efficacy and safety of triiodothyronine supplementation in patients with major depressive disorder treated with specific serotonin reuptake inhibitors Int J Neuropsychopharmacol 11 2008 685 699
7. Bielski R.J., and Friedel R.O. Prediction of tricyclic antidepressant response: a critical review Arch Gen Psychiatry 33 1976 1479 1489
8. Joyce P.R., and Paykel E.S. Predictors of drug response in depression Arch Gen Psychiatry 46 1989 89 99
9. Goodwin F.K. Predictors of antidepressant response Bull Menninger Clin 57 1993 146 160
10. Schatzberg A.F. Noradrenergic versus serotonergic antidepressants: predictors of treatment response J Clin Psychiatry 59 14, suppl 1998 15 18
11. Szegedi A., Müller M.J., Anghelescu I., Klawe C., Kohnen R., and Benkert O. Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression J Clin Psychiatry 64 2003 413 420
12. Nierenberg A.A., McLean N.E., Alpert J.E., Worthington J.J., Rosenbaum J.F., and Fava M. Early nonresponse to fluoxetine as a predictor of poor 8-week outcome Am J Psychiatry 152 1995 1500 1503
13. Nierenberg A.A., Farabaugh A.H., Alpert J.E., Gordon J., Worthington J.J., and Rosenbaum J.F. Timing of onset of antidepressant response with fluoxetine treatment Am J Psychiatry 157 2000 1423 1428
14. Stassen H.H., Delini-Stula A., and Angst J. Time course of improvement under antidepressant treatment: a survival-analytical approach Eur Neuropsychopharmacol 3 1993 127 135
15. Stassen H.H., Angst J., and Delini-Stula A. Delayed onset of action of antidepressant drugs? Survey of results of Zurich meta-analyses Pharmacopsychiatry 29 1996 87 96
16. Stassen H.H., Angst J., and Delini-Stula A. Fluoxetine versus moclobemide: cross-comparison between the time courses of improvement Pharmacopsychiatry 32 1999 56 60
17. Szegedi A., Jansen W.T., van Willigengurg A.P., van der Meulen E., Stassen H.H., and Thase M.E. Early improvement in the first 2 weeks as predictor of treatment outcome in patients with major depressive disorder: a meta-analysis including 6562 patients J Clin Psychiatry 70 2009 344 353
18. Henkel V., Seemuller F., Obermeier M., Adli M., Bauer M., and Mundt C. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from naturalistic study on a large sample of inpatients with major depression J Affec Disord 115 2009 439 449
19. Bares M., Brunovsky M., Kopecek M., Stopkova P., Novak T., and Kozeny J. Changes in QEEG prefrontal cordance as a predictor of response to antidepressants in patients with treatment resistant depressive disorder: a pilot study J Psychiatr Res 41 2007 319 325
20. Yoshida K., Takahashi H., Higuchi H., Kamata M., Ito K., and Sato K. Prediction of antidepressant response to milnacipran by norepinephrine transporter gene polymorphisms Am J Psychiatry 161 2004 1575 1580
21. Fava M., Rush A.J., Alpert J.E., Balasubramani G.K., Wisniewski S.R., and Carmin C.N. Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report Am J Psychiatry 165 2008 342 351
22. Howland R.H., Rush A.J., Wisniewski S.R., Trivedi M.H., Warden D., and Fava M. Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome Drug Alcohol Depend 99 2009 248 260
23. McGrath P.J., Khan A.Y., Trivedi M.H., Stewart J.W., Morris D.W., and Wisniewski S.R. Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report J Clin Psychiatry 69 2008 1847 1855
24. Stewart J.W., McGrath P.J., Fava M., Wisniewski S.R., Zisook S., and Cook I. Do atypical features affect outcome in depressed outpatients treated with citalopram? Int J Neuropsychopharmacol 3 2009 1 16
25. Young E.A., Kornstein S.G., Marcus S.M., Harvey A.T., Warden D., and Wisniewski S.R. Sex differences in response to citalopram: a STAR*D report J Psychiatr Res 43 2009 503 511
26. Stahl S.M. Placebo-controlled comparison of the selective serotonin reuptake inhibitors citalopram and sertraline Biol Psychiatry 48 2000 894 901
27. Abramson J.H., and Abramson Z.H. Making sense of data 3rd ed 2001 Oxford University Press New York
28. Gordis L. Epidemiology 3rd ed 2004 Elsevier-Saunders Pennsylvania
29. Kieser M., and Szegedi A. Predicting stable treatment response in patients with major depression treated with hypericum extract WS 5570/5572 Pharmacopsychiatry 38 2005 194 200